Back
For best output, select "Paper Size" as "A4" and "Margin" as "0" or "None".
To save or print to PDF, please select Print Destination > Save as PDF, enable Background Graphics under "More Settings", then click "Save".
During the congress, E-Posters will be accessible to all participants on the congress website 24/7, as well as in the E-poster stations in the congress center.
Preparing your E-Poster
Please review the E-Poster format requirements carefully when preparing your E-Poster. Should your E-Poster not meet the mentioned requirements, it may not be displayed as described above.
E-Poster Submission Deadline
Please prepare and upload your E-Poster no later than March 14, 2026 11.59PM CET. After this date, you will no longer be able to prepare and upload your E-poster and it will not be displayed and accessible on the congress website.
Please follow the instructions below to input your abstract title.
Abstract titles should be brief and reflect the content of the abstract.
Anemia is a common complication after kidney transplantation and is associated with adverse graft and patient outcomes. Factors such as delayed graft function (DGF) and the use of expanded criteria donors (ECD) may influence erythropoietic recovery. This study aimed to evaluate the relationship between renal function and hemoglobin (Hb) levels after kidney transplantation, and to investigate the impact of DGF and donor criteria on post-transplant anemia.
Clinical and laboratory data were retrospectively collected from 126 kidney transplant recipients at Hospital Santa Casa de Curitiba (Brazil) between January 2018 and July 2023. Hb concentrations and estimated glomerular filtration rate (eGFR) were obtained on postoperative days 1 and 3, at one month, and every three months thereafter up to two years. Correlations between Hb and eGFR were examined, and logistic regression was used to determine the influence of DGF and donor classification (standard versus expanded criteria) on anemia risk.
Hemoglobin levels showed a positive correlation with eGFR (Hb = 10.4 + 0.044 × eGFR; p < 0.001, r = 0.52), indicating improved hemoglobin recovery with higher renal function (Figure 1). The probability of anemia declined markedly from 0.81 on day 3 to 0.27 at day 180, remaining stable thereafter (Figure 2). Recipients with DGF had a lower, though not statistically significant, risk of post-transplant anemia compared with those with immediate graft function (OR = 0.75; 95% CI 0.26–2.19; p = 0.61) (Figure 3). Conversely, recipients of kidneys from ECD presented significantly lower Hb levels during early follow-up (95% CI −1.32 to −0.77; p = 0.028) (Figure 4).
Post-transplant anemia is closely associated with renal function recovery. While DGF was not significantly correlated with anemia, the use of ECD was linked to lower Hb levels and higher anemia risk after transplantation. These findings highlight the importance of early and individualized monitoring of Hb and renal function, particularly in high-risk patients, to improve post-transplant management and outcomes.
